AUG 20, 2021 8:47 AM PDT

Blood Pressure Drugs Boost Survival in Colorectal Cancer

WRITTEN BY: Annie Lennon

Common drugs used to regulate blood pressure may improve survival rates among patients with colorectal cancer, also known as colon cancer. The corresponding study was published in Cancer Medicine by researchers in the US and Brazil. 

Previous studies have found that vascular changes are common in cancers. Furthermore, antihypertensive medications - those that lower blood pressure- have been shown to have an effect on tumors. 

While high blood pressure is common among those with colorectal cancer, there has been little research into the effects of blood pressure medications on patients with colorectal cancer. Researchers thus sought to investigate this topic in the present study. 

To do so, they examined 13,982 colorectal cancer patient outcomes from the Surveillance, Epidemiology, and End-Results (SEER) Medicare database. All patients were aged 65 or older and were diagnosed with the cancer between 2007 and 2012. 

The researchers found that patients using ACE inhibitors and thiazide diuretics benefited most in terms of survival and outcomes. Those on calcium-channel blockers, however, benefited less. Patients who took their blood pressure medications consistently also had lower mortality rates. 

 "Our results show an association between increased adherence to [blood-pressure] medications and reduced … mortality in patients starting these medications after stage I, II or III CRC diagnosis relative to those who did not," wrote the researchers of their findings. 

"It is heartening to note that we could confirm the results of the animal model work done by Dr. Roger Chammas and colleagues at the University of São Paulo Cancer Center in a human population as well," said Rajesh Balkrishnan, one of the authors of the paper. 

"We will continue to explore these protective effects of antihypertensives on other cancers as well in human populations using stronger study designs. This could potentially provide significant implications for gastrointestinal cancer treatment,” he added. 

 

Sources: Cancer MedicineScience Daily

 

About the Author
  • Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
AUG 10, 2021
Immunology
A Tapeworm Drug as a COVID Antiviral?
AUG 10, 2021
A Tapeworm Drug as a COVID Antiviral?
A study by researchers at the Scripps Research Institute looking into potential COVID-19 medications has revealed a surp ...
AUG 12, 2021
Cancer
Promising Drug Target Identified for Deadly Ovarian Cancer
AUG 12, 2021
Promising Drug Target Identified for Deadly Ovarian Cancer
Scientists at the University of Alabama at Birmingham have identified a gene called DOT1L for its role in progressing th ...
AUG 13, 2021
Drug Discovery & Development
Breast Cancer Drug Reverses Deadly Blood Cancer in Mice
AUG 13, 2021
Breast Cancer Drug Reverses Deadly Blood Cancer in Mice
A drug currently used to treat advanced breast cancers may treat a rare type of leukemia known as myelofibrosis. The stu ...
SEP 20, 2021
Genetics & Genomics
Clinical Trial of CRISPR-Based HIV Treatment Set to Begin
SEP 20, 2021
Clinical Trial of CRISPR-Based HIV Treatment Set to Begin
Human immunodeficiency virus (HIV) is a retrovirus, which is a type of virus that can write its genetic material into th ...
SEP 21, 2021
Drug Discovery & Development
Lifesaving TheraSpheres - glass microbeads can target and destroy colorectal tumors
SEP 21, 2021
Lifesaving TheraSpheres - glass microbeads can target and destroy colorectal tumors
The innovative medical device manufacturer Boston Scientific recently showed success in treating patients with ...
OCT 01, 2021
Technology
SnapTec® - Single-handed operation for fast and safe sample handling
OCT 01, 2021
SnapTec® - Single-handed operation for fast and safe sample handling
The new Eppendorf Conical Tube SnapTec 50 offers all the advantages of classic conical tubes 50 mL. The decisive, innova ...
Loading Comments...